Isolation and structure characterization of related impurities in Sodium Tanshinone IIA Sulfonate by LC/ESI-MS n and NMR

Journal of Pharmaceutical and Biomedical Analysis

Volumn 67-68, Issue , 2012, Pages 36-41

  Wang, Baolin ^a   Wang, Hao ^a   Wang, En ^a   Yan, Wenjing ^a   Ye, Wencai ^a,b   Li, Ping ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Isolation; LC ESI MS n; NMR; Related impurities; Sodium Tanshinone IIA Sulfonate

Indexed keywords

ANTINEOPLASTIC AGENT; SODIUM 1,2 DIHYDROTANSHINONE IIA SULFONATE; SODIUM 1,2 DIHYDROTANSHINONE SULFONATE; SODIUM 1,6 DIHYDROXYL 15,16 DIHYDROTANSHINONE IIA SULFONATE; SODIUM 3 HYDROXYL SALVIANOLIC ACID SULFONATE; SODIUM HYDROXYL TANSHINONE SULFONATE; SODIUM SALVIANOLIC ACID SULFONATE; SODIUM TANSHINONE I SULFONATE; SODIUM TANSHINONE IIB SULFONATE; TANSHINONE IIA; TANSHINONE IIA SULFONIC ACID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COLUMN CHROMATOGRAPHY; DRUG ISOLATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

CHROMATOGRAPHY, LIQUID; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PHENANTHRENES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84862148356     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.04.029     Document Type: Article

References (12)

1. Shanghai Cooperative Group for the Study of Tanshinone IIA Therapeutic effect of sodium tanshinone IIA sulfonate in patients with coronary heart disease: a double blind study. J. Tradit. Chin. Med. 1984, 4:20-24.
2. Wu T.W., Zeng L.H., Fung K.P., Wu J., Pang H., Grey A.A., Weisel R.D., Wang J.Y. Effect of sodium tanshinone IIA sulfonate in the rabbit myocardium and on human cardiomyocytes and vascular endothelial cells. Biochem. Pharmacol. 1993, 46:2327-2332.
3. Zhou G.Y., Jiang W., Zhao Y., Ma G.G., Xin W.J., Yin J.J., Zhao B.L. Sodium tanshinone IIA sulfonate mediates electron transfer reaction in rat heart mitochondria. Biochem. Pharmacol. 2003, 65:51-57.
4. + channels by sodium tanshinoneII-A sulfonate (DS-201) in porcine coronary artery smooth muscle cells. Eur. J. Pharmacol. 2008, 598:9-15.
5. Ca activation in mouse cerebral arterial smooth muscle cells. Eur. J. Pharmacol. 2011, 656:27-32.
6. Huang Y.F., Liu M.L., Dong M.Q., Yang W.C., Zhang B., Luan L.L., Dong H.Y., Xu M., Wang Y.X., Liu L.L., Gao Y.Q., Li Z.C. Effects of sodium tanshinone IIA sulphonate on hypoxic pulmonary hypertension in rats in vivo and on Kv2.1 expression in pulmonary artery smooth muscle cells in vitro. J. Ethnopharmacol. 2009, 125:436-443.
7. Mao S.J., Jin H., Bi Y.Q., Liang Z., Li H., Hou S.X. Ion-pair reversed-phase HPLC method for determination of sodium tanshinone IIA sulfonate in biological samples and its pharmacokinetics and biodistribution in mice. Chem. Pharm. Bull. 2007, 55:753-756.
8. Mao S.J., Hou S.X., Liang Z., Bi Y.Q., Wu Y., Li H., Jin H. Ion-pair reversed-phase HPLC: assay validation of sodium tanshinone IIA sulfonate in mouse plasma. J. Chromatogr. B 2006, 831:163-168.
9. Hao H.P., Wang G.J., Cui N., Li J., Ding Z.Q. Determination of sodium tanshinone IIA sulfonate in plasma by liquid chromatography-electrospray ionisation-tandem mass spectrometry. Biomed. Chromatogr. 2007, 21:1172-1179.
10. Zou Q.G., Huang B.Y., He T.T., Wei P., Zhang Z.J., Ouyang P.K. Identification, isolation, and characterization of impurities in sodium tanshinone IIA sulfonate. J. Liq. Chromatogr. Relat. Technol. 2009, 32:2346-2360.
11. ICH Guideline Q3A (R), Impurities in New Drug Substances, February 7, 2002.
12. Sun J.H., Yang M., Han J., Wang B.R., Ma X.C., Xu M., Liu P., Guo D. Profiling the metabolic difference of seven tanshinones using high-performance liquid chromatography/multi-stage mass spectrometry with data-dependent acquisition. Rapid Commun. Mass Spectrom. 2007, 21:2211-2226.